Showing 5,961 - 5,980 results of 43,621 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((teer decrease) OR (mean decrease)) ))', query time: 0.82s Refine Results
  1. 5961

    Image4_Analysis of Geometric and Hemodynamic Profiles in Rat Arteriovenous Fistula Following PDE5A Inhibition.tif by Hannah Northrup (5938436)

    Published 2021
    “…In both groups: 1) CSA increased from the 0–5 to 15–20 zone; 2) velocity, WSS, and vorticity were highest in the 0–5 zone and dropped significantly thereafter; and 3) OSI increased at the 5–10 zone and then decreased gradually. …”
  2. 5962

    Data_Sheet_1_Truncation or Deglycosylation of the Neuraminidase Stalk Enhances the Pathogenicity of the H5N1 Subtype Avian Influenza Virus in Mallard Ducks.docx by Sujuan Chen (305824)

    Published 2020
    “…<p>H5N1 subtype avian influenza virus (AIV) with a deletion of 20 amino acids at residues 49–68 in the stalk region of neuraminidase (NA) became a major epidemic virus. …”
  3. 5963
  4. 5964
  5. 5965

    Summary of demographics for all cohorts. by Emily Baker (3492485)

    Published 2023
    “…Variability in the estimation of SNP-based heritability could explain the differences in reported heritability.</p><p>Methods</p><p>We compute heritability in five large independent cohorts (N = 7,396, 1,566, 803, 12,528 and 3,963) to determine whether a consensus for the AD heritability estimate can be reached. …”
  6. 5966

    S1 Data - by Emily Baker (3492485)

    Published 2023
    “…Variability in the estimation of SNP-based heritability could explain the differences in reported heritability.</p><p>Methods</p><p>We compute heritability in five large independent cohorts (N = 7,396, 1,566, 803, 12,528 and 3,963) to determine whether a consensus for the AD heritability estimate can be reached. …”
  7. 5967
  8. 5968
  9. 5969

    Table_1_Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats.docx by Tetsuya Tajima (16382574)

    Published 2023
    “…Tacrolimus was daily administered until post-transplant day (PTD)-7 or sacrifice to suppress cellular rejections. Using this model, we validated the efficacy of anti-C5 antibody (Anti-C5) for LT-AMR. …”
  10. 5970
  11. 5971

    Data_Sheet_5_Impacts of Temperature, CO2, and Salinity on Phytoplankton Community Composition in the Western Arctic Ocean.PDF by Koji Sugie (758364)

    Published 2020
    “…Further, the increasing area and duration of sea ice-free conditions enhance ocean uptake of CO<sub>2</sub>. We conducted two shipboard experiments in September 2015 and 2016 to examine the effects of temperature, CO<sub>2</sub>, and salinity on phytoplankton dynamics to better understand the impacts of rapid environmental changes on the Arctic ecosystem. …”
  12. 5972

    Image_5_Coptisine Alleviates Pristane-Induced Lupus-Like Disease and Associated Kidney and Cardiovascular Complications in Mice.tif by Yu Yan (261782)

    Published 2020
    “…Considering that Rho-associated coiled-coil-containing protein kinases (ROCKs) play important roles in SLE, inflammation, and cardiovascular disease, we hypothesized that coptisine, which has been found to inhibit ROCKs, may have an effect on SLE. …”
  13. 5973

    Image_5_Trends and patterns in the global burden of intracerebral hemorrhage: a comprehensive analysis from 1990 to 2019.TIF by Tong Sun (1564231)

    Published 2023
    “…</p>Conclusion<p>While the ASDR and DALY rates decreased from 1990 to 2019, the decline in ASIR was less pronounced. …”
  14. 5974
  15. 5975

    β5i Subunit Deficiency of the Immunoproteasome Leads to Reduced Th2 Response in OVA Induced Acute Asthma by Anton Volkov (399237)

    Published 2013
    “…Here, we present novel evidence for the requirement of the β5i immunosubunit to generate a strong Th2 response during OVA- but not HDM-induced acute asthma. …”
  16. 5976
  17. 5977
  18. 5978

    Data Sheet 1_Global, regional, and national burden of neonatal otitis media attributable to PM2.5 air pollution: findings from the Global Burden of Disease study 2021.pdf by Xin Gong (592328)

    Published 2025
    “…</p>Methods<p>Using data from the Global Burden of Disease (GBD) study 2021, we estimated the number and rates of disability-adjusted life years (DALYs) and years lived with disability (YLDs) associated with PM2.5-related OM in neonates. …”
  19. 5979

    Table 2_Safety profile of complement C5 inhibitors and FcRn inhibitors in the treatment of myasthenia gravis: analysis of the FAERS database and disease-gene interaction network.do... by Luqiong Wang (22389295)

    Published 2025
    “…Additionally, network pharmacology was employed to analyze the toxicity mechanisms of the system organ categories (SOCs) specifically associated with complement C5 inhibitors and FcRn inhibitors.</p>Results<p>Signal detection of AE reports associated with these five drugs revealed previously unlabeled positive signals, including: eculizumab (gastric cancer, embolic stroke), ravulizumab (psoriatic arthropathy, hypoacusis, peripheral vascular disorders), zilucoplan (weight increased, weight decreased), efgartigimod (metastases to liver, hepatic failure, nephrolithiasis, dysuria, Prostatitis, prostate cancer, Angina pectoris, congestive cardiac failure) and rozanolixizumab (vomiting, dyspepsia). …”
  20. 5980

    Table 1_Safety profile of complement C5 inhibitors and FcRn inhibitors in the treatment of myasthenia gravis: analysis of the FAERS database and disease-gene interaction network.do... by Luqiong Wang (22389295)

    Published 2025
    “…Additionally, network pharmacology was employed to analyze the toxicity mechanisms of the system organ categories (SOCs) specifically associated with complement C5 inhibitors and FcRn inhibitors.</p>Results<p>Signal detection of AE reports associated with these five drugs revealed previously unlabeled positive signals, including: eculizumab (gastric cancer, embolic stroke), ravulizumab (psoriatic arthropathy, hypoacusis, peripheral vascular disorders), zilucoplan (weight increased, weight decreased), efgartigimod (metastases to liver, hepatic failure, nephrolithiasis, dysuria, Prostatitis, prostate cancer, Angina pectoris, congestive cardiac failure) and rozanolixizumab (vomiting, dyspepsia). …”